best mid cap stock march 3, 2017 to march 16, 2017

TG Therapeutics (TGTX) had the highest return between March 3, 2017 and March 16, 2017 by a mid-cap US stock, returning 148.2%.

ASSET DATE % RETURN
TG Therapeutics (TGTX)
3/3/2017 - 3/16/2017
148.21%
HUTCHMED DRC (HCM)
3/3/2017 - 3/16/2017
39.12%
National Beverage (FIZZ)
3/3/2017 - 3/16/2017
28.21%
Catalyst Pharmaceuticals (CPRX)
3/3/2017 - 3/16/2017
27.97%
Mesoblast (MESO)
3/3/2017 - 3/16/2017
23.12%
Transportadora de Gas del Sur SA ADR (TGS)
3/3/2017 - 3/16/2017
19.21%
Cytokinetics (CYTK)
3/3/2017 - 3/16/2017
19.2%
H&R Block (HRB)
3/3/2017 - 3/16/2017
18.71%
Centerra Gold (CGAU)
3/3/2017 - 3/16/2017
17.21%
Ocular Therapeutix (OCUL)
3/3/2017 - 3/16/2017
16.73%
RH (RH)
3/3/2017 - 3/16/2017
16.6%
Seabridge Gold (SA)
3/3/2017 - 3/16/2017
16.32%
Soleno Therapeutics (SLNO)
3/3/2017 - 3/16/2017
16.27%
Skeena Resources (SKE)
3/3/2017 - 3/16/2017
16%
Freshpet (FRPT)
3/3/2017 - 3/16/2017
15.98%
Primo Brands (PRMB)
3/3/2017 - 3/16/2017
15.95%
Option Care Health (OPCH)
3/3/2017 - 3/16/2017
14.69%
Uranium Energy (UEC)
3/3/2017 - 3/16/2017
14.07%
SiteOne Landscape Supply (SITE)
3/3/2017 - 3/16/2017
13.98%
Scorpio Tankers (STNG)
3/3/2017 - 3/16/2017
13.7%
Camtek (CAMT)
3/3/2017 - 3/16/2017
13.06%
Riot Blockchain (RIOT)
3/3/2017 - 3/16/2017
13.05%
SK Telecom Co Ltd ADR (SKM)
3/3/2017 - 3/16/2017
12.73%
Galapagos NV ADR (GLPG)
3/3/2017 - 3/16/2017
11.69%
Penn National Gaming (PENN)
3/3/2017 - 3/16/2017
11.53%
Mid-cap stocks are treated as having a market cap between $2B and $10B.